The studies by Karlsen et al. 22 and Gaj et al. 23 did not show an impact of NOD2 variants on the development of primary sclerosing cholangitis (PSC) or primary biliary cholangitis (PBC), respectively. The gene discussed is NOD2; the disease is biliary liver cirrhosis.